No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 7, 2011, Pages 868-874

  Li, Hung Kei ^a   Chen, Frank C ^a   Rea, Robert F ^a   Asirvatham, Samuel J ^a   Powell, Brian D ^a   Friedman, Paul A ^a   Shen, Win Kuang ^a   Brady, Peter A ^a   Bradley, David J ^a   Lee, Hon Chi ^a   Hodge, David O ^a   Slusser, Joshua P ^a   Hayes, David L ^a   Cha, Yong Mei ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aspirin; Heparin; International normalized ratio; Medical device; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DRUG SAFETY; EMBOLISM PREVENTION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ASSIST DEVICE; HEMATOMA; HEMATURIA; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POCKET HEMATOMA; RETROSPECTIVE STUDY; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

AGED; ANTICOAGULANTS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEMORRHAGE; HEPARIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; WARFARIN;

EID: 84860401724     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03049.x     Document Type: Article

References (20)

1. Goto Y, Abe T, Sekine S, Sakurada T. Long-term thrombosis after tranvenous permanent pacemaker implantation. Pacing Clin Electrophysiol 1998;21:1192-1195. (Pubitemid 28270050)
2. Przybylski A, Sterlinski M, Lewandowski M, Srzednicki M, Wolski P, Maciag A, Pytkowski M, et al. Risk of thromboembolic complications in patients with permanent atrial fibrillation undergoing cardioverter-defibrillator implantation. Kardiol Pol 2002;57:306-312.
3. Moore III JW, Barrington W, Bazaz R, Jain S, Nemec J, Ngwu O, Schwartzman D, et al. Complications of replacing implantable devices in response to advisories: A single center experience. Int J Cardiol 2009;134:42-46.
4. Wiegand U, LeJeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, Bode F. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery. Chest 2004;126:1177-1186.
5. Hammerstingl C, Tripp C, Schmidt H, von der Recke G, Omran H. Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: Experience in 116 patients from the prospective BRAVE registry. J Heart Valve Dis 2007;16:285-292. (Pubitemid 46887057)
6. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007;116:1349-1355. (Pubitemid 47417560)
7. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, et al. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 2008;52:e1-e142.
8. Goldstein DJ, Losquadro W, Spotnitz HM. Outpatient pacemaker procedures in orally anticoagulated patients. Pacing Clin Electrophysiol 1998;21:1730-1734. (Pubitemid 28415469)
9. Al-Khadra A. Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients. Pacing Clin Electrophysiol 2003;26:511-514. (Pubitemid 36399207)
10. Giudici MC, Barold SS, Paul DL, Bontu P. Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy. Pacing Clin Electrophysiol 2004;27:358-360. (Pubitemid 38352516)
11. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870. (Pubitemid 32537350)
12. Baudet EM, Oca CC, Roques XF, Laborde MN, Hafez AS, Collot MA, Ghidoni IM. A 5 1/2 year experience with the St. Jude Medical cardiac valve prosthesis. Early and late results of 737 valve replacements in 671 patients. J Thorac Cardiovasc Surg 1985;90:137-144. (Pubitemid 15016437)
13. Michaud GF, Pelosi F Jr, Noble MD, Knight BP, Morady F, Strickberger SA. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol 2000;35:1915-1918. (Pubitemid 30342875)
14. Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, Baranchuk A, et al. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol 2009;32:378-382.
15. Ahmed I, Gertner E, Nelson WB, House CM, Dahiya R, Anderson CP, Benditt DG, et al. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. Heart Rhythm 2010;7:745-749.
16. Milic DJ, Perisic ZD, Zivic SS, Stanojkovic ZA, Stojkovic AM, Karanovic ND, Krstic NH, et al. Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment. Europace 2005;7:374-379. (Pubitemid 40790423)
17. Tolosana JM, Berne P, Mont L, Heras M, Berruezo A, Monteagudo J, Tamborero D, et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: Oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial. EurHeart J 2009;30:1880-1884.
18. Thal S, Goldman S. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation. Pacing Clin Electrophysiol 2010;33:385-388.
19. Ghanbari H, Feldman D, Schmidt M, Ottino J, Machado C, Akoum N, Wall TS, et al. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol 2010;33:400-406.
20. Birnie D, Healey JS, Krahn A, Essebag V, Sivakumaran S, Tang A, Simpson C. Bridge or continue Coumadin for device surgery: A randomized controlled trial rationale and design. Curr Opin Cardiol 2008;24:82-87.